(Q40710173)

23 September 2017

Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer (English)

1 reference

23 September 2017

8

1 reference

23 September 2017

Aseem Anand

7

0 references

Howard I Scher

11

object named as

Howard I Scher

1 reference

23 September 2017

Margaret A Leversha

1

1 reference

23 September 2017

Jialian Han

2

1 reference

23 September 2017

Zahra Asgari

3

1 reference

23 September 2017

Daniel C Danila

4

1 reference

23 September 2017

Oscar Lin

5

1 reference

23 September 2017

Rita Gonzalez-Espinoza

6

1 reference

23 September 2017

Glenn Heller

9

1 reference

23 September 2017

Martin Fleisher

10

1 reference

23 September 2017

language of work or name

English

0 references

publication date

10 March 2009

1 reference

23 September 2017

Clinical Cancer Research

1 reference

23 September 2017

15

1 reference

23 September 2017

6

1 reference

23 September 2017

2091-2097

1 reference

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

23 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875199

Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875199

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875199

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875199

Comparison of chromosomal and array-based comparative genomic hybridization for the detection of genomic imbalances in primary prostate carcinomas

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875199

The new cytogenetics: blurring the boundaries with molecular biology

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875199

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875199

Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875199

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875199

DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875199

Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875199

Mapping and gene expression profile of the minimally overrepresented 8q24 region in prostate cancer

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875199

Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875199

Prognostic value of deoxyribonucleic acid content in prostate cancer: a review of current results

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875199

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875199

Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875199

Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875199

Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer

19 August 2018

1 reference

12 December 2020

Genetic evaluation of localized prostate cancer in a cohort of forty patients: gain of distal 8q discriminates between progressors and nonprogressors

1 reference

12 December 2020

Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer

1 reference

12 December 2020

Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization

1 reference

12 December 2020

Increased cell proliferation activity and decreased cell death are associated with the emergence of hormone-refractory recurrent prostate cancer

1 reference

12 December 2020

Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma

1 reference

12 December 2020

Distribution of Human Chromosome Counts in Relation to Age

1 reference

12 December 2020

Androgen receptor amplification is associated with increased cell proliferation in prostate cancer

1 reference

12 December 2020

Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer

1 reference

12 December 2020

Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

1 reference

12 December 2020

FISH analysis of gene aberrations (MYC, CCND1, ERBB2, RB, and AR) in advanced prostatic carcinomas before and after androgen deprivation therapy

1 reference

12 December 2020

10.1158/1078-0432.CCR-08-2036

Identifiers

DOI

1 reference

23 September 2017

1 reference

23 September 2017

PubMed publication ID

19276271

1 reference